ProMIS Neurosciences Inc. Common Shares (ON) (PMN) Stock Price

PMNStock

$15.36+9.63%52W

Market Cap$137.74M

P/E—

PEG Ratio—

Div yield—

Beta-0.27

PMN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-20.39%

Price vs S&P 500 (4W)-1.12%

VGM Score60.53

Book Value / Share (Quarterly)$6.77

P/TBV (Annual)5.79x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-3.97

Price vs S&P 500 (YTD)104.73%

Net Profit Margin (TTM)-12900.00%

EPS (TTM)$-18.59

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-18.59

EPS (Annual)$-1.07

ROI (Annual)-352.02%

Net Profit Margin (5Y Avg)-12306.41%

Cash / Share (Quarterly)$7.12

ROA (Last FY)-97.01%

EBITD / Share (TTM)$-13.28

ROE (5Y Avg)-725.53%

Operating Margin (TTM)-12900.00%

Cash Flow / Share (Annual)$-13.06

P/B Ratio2.18x

P/B Ratio (Quarterly)1.88x

Net Income / Employee (Annual)$-2,202,100

Net Interest Coverage (TTM)-5.53x

ROA (TTM)-151.04%

EPS Incl Extra (Annual)$-1.07

Current Ratio (Annual)0.88x

Quick Ratio (Quarterly)9.69x

3-Month Avg Trading Volume0.07M

52-Week Price Return9.63%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.20

P/S Ratio (Annual)13263.22x

Asset Turnover (Annual)0.01x

52-Week High$27.40

Operating Margin (5Y Avg)-12266.41%

EPS Excl Extra (Annual)$-1.07

26-Week Price Return-9.15%

Quick Ratio (Annual)0.60x

13-Week Price Return36.41%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.92x

Enterprise Value$68.82M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-46400.00%

Cash / Share (Annual)$2.86

3-Month Return Std Dev92.61%

Net Income / Employee (TTM)$-6,769,300

ROE (Last FY)-352.02%

EPS Basic Excl Extra (Annual)$-1.07

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-18.59

Receivables Turnover (Annual)0.29x

ROI (TTM)-56.72%

P/S Ratio (TTM)13263.22x

Pretax Margin (5Y Avg)-12306.41%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$4.97

Price vs S&P 500 (52W)-8.68%

Year-to-Date Return116.69%

5-Day Price Return-1.20%

EPS Normalized (Annual)$-1.07

ROA (5Y Avg)-229.81%

Net Profit Margin (Annual)-46400.00%

Month-to-Date Return7.87%

Cash Flow / Share (TTM)$-1.78

EBITD / Share (Annual)$-1.16

Operating Margin (Annual)-46300.00%

LT Debt / Equity (Annual)0.69x

ROI (5Y Avg)-711.40%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-18.59

P/TBV (Quarterly)5.79x

P/B Ratio (Annual)1.88x

Pretax Margin (TTM)-12900.00%

Book Value / Share (Annual)$12.61

Price vs S&P 500 (13W)33.61%

Beta-0.27x

Revenue / Share (TTM)$0.00

ROE (TTM)-56.72%

52-Week Low$6.27

mGradeB

vgmGradeB

PMN Earnings Surprise History

Q2 25-9.98est. -6.04

Q3 25-8.40est. -9.99

Q4 25-30.05est. -6.71

Q2 26-1.78est. -1.90

PMN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.11

4.10

4.08

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
PMNProMIS Neurosciences Inc. Common Shares (ON)	—	—	B	$15.36
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About ProMIS Neurosciences Inc. Common Shares (ON)

ProMIS Neurosciences is a clinical-stage biotechnology company developing antibody therapeutics for neurodegenerative diseases, including Alzheimer's disease, ALS, and multiple system atrophy. The company uses its proprietary ProMIS platform to identify and target toxic misfolded proteins that drive neurodegeneration.